8-KThe WireRoutine
Shareholder Vote
Filed Jun 28, 2024 · 2y ago · Accession 0000950170-24-079059
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Janux Therapeutics, Inc.
- Ticker
- JANX
- CIK
- 1817713
- Form type
- 8-K
- Filing date
- Jun 28, 2024
- Report date
- Jun 26, 2024
- Document
- janx-20240626.htm
- Size
- 174 KB